Evidence map›Paper›PMID 3734096›Full record

ArticleThe Journal of clinical investigation1986

Unique antigen of cultured Hodgkin's cells. A putative sialyltransferase.

E Paietta, R J Stockert, A G Morell, V Diehl, P H Wiernik

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1986. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

E Paietta
R J Stockert
A G Morell
V Diehl
P H Wiernik
California Liver Research Institute · USYeshiva University · USMontefiore Medical Center · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI ALYSON B MOADEL · 1985 to 2026
$111.2M
TRANSFERRIN AND HEPATIC IRON METABOLISMP50AM017702 · AM · YESHIVA UNIVERSITY · PI SHAFRITZ, DAVID A · 1985 to 1985
–
HEPATIC UPTAKE AND TRANSPORT MECHANISMSR01AM032419 · AM · YESHIVA UNIVERSITY · PI WOLKOFF, ALLAN W · 1985 to 1985
–
NCI NIH HHS P30CA13330NIADDK NIH HHS AM-17702NIADDK NIH HHS AM-32419
6 · The paper itself

Abstract

Hodgkin's disease-derived giant cell lines (HD-cells) express high levels of ectosialyltransferase activity presumed to be a galactose-specific lectin recognizing the desialylated 3-fucosyl-N-acetyllactosamine structure (X-hapten). Both the anti-X-hapten monoclonal antibody VIM-D5 and a polyclonal antiserum to another galactose-lectin, the hepatic asialoglycoprotein receptor (HBP), recognize a 55,000-mol wt HD-cell protein (Paietta, E., R. J. Stockert, A. G. Morell, V. Diehl, and P. H. Weirnik. 1986. Proc. Natl. Acad. Sci. USA. 83:3451-3455.) That the expression of the 55,000-mol wt protein is restricted to HD-cells among X-hapten positive cells lines is confirmed in this study. The 55,000-mol wt protein is shown to be present on the cell surface and intracellularly, where an additional immunocrossreactive 150,000-mol wt protein is recognized. Extraction of the 55,000 mol wt protein from HD-cell lysates by affinity chromatography results in the loss of sialyltransferase activity. While evidence for a single protein possessing both the antigenic and the enzymatic activity is not direct, these results suggest that the ectosialyltransferase unique to HD-cells is a 55,000-mol wt membrane glycoprotein possessing the X-hapten oligosaccharide.

Indexed as

Asialoglycoprotein ReceptorAntibodies, NeoplasmAntigens, NeoplasmBinding, CompetitiveBinding Sites, AntibodyCarrier ProteinsCell CompartmentationCell LineCell MembraneHodgkin DiseaseHumansImmune SeraPrecipitin TestsSialyltransferasesTransferasesAntibodies, NeoplasmAntigens, NeoplasmAsialoglycoprotein ReceptorCarrier Proteinshepatic sialoglycoprotein receptorImmune SeraSialyltransferasesTransferases

Identifiers

PMID3734096
PMCPMC423549
OpenAlexW2039731929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.